Essigmann JM - Search Results

1

Excision of mutagenic replication-blocking lesions suppresses cancer but promotes cytotoxicity and lethality in nitrosamine-exposed mice.

Kay JE, Corrigan JJ, Armijo AL, Nazari IS, Kohale IN, Torous DK, Avlasevich SL, Croy RG, Wadduwage DN, Carrasco SE, Dertinger SD, White FM, Essigmann JM, Samson LD, Engelward BP. Kay JE, et al. Among authors: essigmann jm. Cell Rep. 2021 Mar 16;34(11):108864. doi: 10.1016/j.celrep.2021.108864. Cell Rep. 2021. PMID: 33730582 Free PMC article.

2

Relative efficiencies of the bacterial, yeast, and human DNA methyltransferases for the repair of O6-methylguanine and O4-methylthymine. Suggestive evidence for O4-methylthymine repair by eukaryotic methyltransferases.

Sassanfar M, Dosanjh MK, Essigmann JM, Samson L. Sassanfar M, et al. Among authors: essigmann jm. J Biol Chem. 1991 Feb 15;266(5):2767-71. J Biol Chem. 1991. PMID: 1993655 Free article.

3

Aflatoxin B1: correlations of patterns of metabolism and DNA modification with biological effects.

Croy RG, Essigmann JM, Wogan GN. Croy RG, et al. Among authors: essigmann jm. Basic Life Sci. 1983;24:49-62. doi: 10.1007/978-1-4684-4400-1_3. Basic Life Sci. 1983. PMID: 6407467 No abstract available.

4

Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor.

Rink SM, Yarema KJ, Solomon MS, Paige LA, Tadayoni-Rebek BM, Essigmann JM, Croy RG. Rink SM, et al. Among authors: essigmann jm. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15063-8. doi: 10.1073/pnas.93.26.15063. Proc Natl Acad Sci U S A. 1996. PMID: 8986764 Free PMC article.

5

Cisplatin adducts inhibit 1,N(6)-ethenoadenine repair by interacting with the human 3-methyladenine DNA glycosylase.

Kartalou M, Samson LD, Essigmann JM. Kartalou M, et al. Among authors: essigmann jm. Biochemistry. 2000 Jul 11;39(27):8032-8. doi: 10.1021/bi000417h. Biochemistry. 2000. PMID: 10891085

6

Design of DNA damaging agents that hijack transcription factors and block DNA repair.

Essigmann JM, Rink SM, Park HJ, Croy RG. Essigmann JM, et al. Adv Exp Med Biol. 2001;500:301-13. doi: 10.1007/978-1-4615-0667-6_47. Adv Exp Med Biol. 2001. PMID: 11764957 Review. No abstract available.

7

A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells.

Mitra K, Marquis JC, Hillier SM, Rye PT, Zayas B, Lee AS, Essigmann JM, Croy RG. Mitra K, et al. Among authors: essigmann jm. J Am Chem Soc. 2002 Mar 6;124(9):1862-3. doi: 10.1021/ja017344p. J Am Chem Soc. 2002. PMID: 11866593 Free PMC article.

8

Design, synthesis, and evaluation of estradiol-linked genotoxicants as anti-cancer agents.

Sharma U, Marquis JC, Nicole Dinaut A, Hillier SM, Fedeles B, Rye PT, Essigmann JM, Croy RG. Sharma U, et al. Among authors: essigmann jm. Bioorg Med Chem Lett. 2004 Jul 16;14(14):3829-33. doi: 10.1016/j.bmcl.2004.04.064. Bioorg Med Chem Lett. 2004. PMID: 15203171 Free PMC article.

9

Disruption of gene expression and induction of apoptosis in prostate cancer cells by a DNA-damaging agent tethered to an androgen receptor ligand.

Marquis JC, Hillier SM, Dinaut AN, Rodrigues D, Mitra K, Essigmann JM, Croy RG. Marquis JC, et al. Among authors: essigmann jm. Chem Biol. 2005 Jul;12(7):779-87. doi: 10.1016/j.chembiol.2005.05.009. Chem Biol. 2005. PMID: 16039525

10

AlkB reverses etheno DNA lesions caused by lipid oxidation in vitro and in vivo.

Delaney JC, Smeester L, Wong C, Frick LE, Taghizadeh K, Wishnok JS, Drennan CL, Samson LD, Essigmann JM. Delaney JC, et al. Among authors: essigmann jm. Nat Struct Mol Biol. 2005 Oct;12(10):855-60. doi: 10.1038/nsmb996. Epub 2005 Oct 2. Nat Struct Mol Biol. 2005. PMID: 16200073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page